.png)
Initially, we’ll need Optum Rx audit determination letters, audit reports, and potential financial records, such as credit card receipts or remittances. As we formulate technical arguments, additional documentation may be requested. We will provide specifics on supporting materials.
Retaliation for exercising Optum Rx audit appeal rights is prohibited. We incorporate proper legal protections into Optum Rx audit responses and settlements. Maintaining existing contracts is always a priority.
Lack of proper 30-day written Optum Rx audit notice violates statute in many states. We leverage penalties around insufficient notice periods into negotiation leverage for your pharmacy.
We offer flexible fee arrangements based on the scope of representation required and Optum Rx audit stage. The earlier we are involved the better, as we can shape and limit Optum Rx audit scope, making legal representation more effective and less costly.
PBMs like Optum Rx often unfairly focus on independent, specialty, and compounding pharmacies versus large chains. But all pharmacy types must contend with aggressive Optum Rx audits. Having legal advocates levels the playing field.
Absolutely. We provide tailored compliance recommendations so pharmacies can reinforce areas prone to Optum Rx audit scrutiny. Proper documentation is critical to rebutting Optum Rx audit allegations.
Yes. We ensure that Optum Rx audit sanctions comply with applicable federal and state laws. PBMs like Optum Rx are prohibited from acting in bad faith or arbitrarily under both applicable law and the parties’ agreements.
Potentially. Depending on the scope of the Optum Rx audits and the claims involved, any clawbacks should be reconciled in DIR, or BER/GER performance metrics. Our specialists ensure that any downstream Optum Rx audit consequences are handled properly in your favor.
We hold PBMs like Optum Rx accountable to their audit and legal obligations. Do not wait until your rights are lost. Schedule a free consultation now.
To design an effective Optum Rx audit response strategy, providers must understand the chain of events both prior to the initiation of an Optum Rx audit and afterwards. For example, Special Investigative Units (SIUs) are often the genesis of an Optum Rx audit, and the presence or absence of "audit risk factors" is informative on potentially broader exposure beyond the claims under audit. Any decision to resolve an Optum Rx audit should be informed and result in a full and final settlement of all liability, but Optum Rx audit settlements need to be structured carefully to achieve this goal.
CVS Caremark, OptumRx, and Express Scripts, control at least 80% of the market, making them the three biggest PBMs. Humana also ranks among the largest. In addition, these PBMs regulate access to networks for smaller competitors, such as ESI's partnership with Prime. Plan sponsors, such as United Health, Cigna and Aetna, are vertically integrated with these PBMs, increasing audit risk for pharmacies because network sanctions are more likely to affect a significant aspect of a pharmacy's business across both government and commercial claims.
PBMs like Optum Rx and payors use artificial intelligence and data mining across medical and pharmacy claims to identify areas of potential inquiry. Among other areas, these inquiries typically involve high-reimbursing medicines, brand/generic substitution, inventory discrepancies, co-payment collection, prior authorization, and telehealth relations. Separately, DEA conducts audits and inspections for compliance to controlled substance regulations.
Common types of Optum Rx audits include desk audits; on-site audits; invoice audits; and prescription audits. Irrespective of the type of Optum Rx audit, all interactions with PBMs like Optum Rx should be taken extremely seriously and can lead to severe consequences if not handled appropriately. For example, there has been a sharp increase in the federal prosecution of pharmacists for audit-related conduct, including answering PBM questions incorrectly. Accordingly, pharmacies should consider using Optum Rx audit counsel to avoid these pitfalls.
Pharmacies can take various steps to prepare to meet Optum Rx audits, including routine self-audits. In fact, the government publishes comprehensive guidance and a checklist to assist pharmacies in their audit planning, including self-audits around prescribing practices, controlled substance management, invoice management, and billing practices. If you need assistance designing or implementing an Optum Rx audit protection plan, please do not hesitate to contact us.
Defending against a Optum Rx audit requires comprehensive knowledge of the rights, responsibilities, and intricacies of pharmacies and their laws and regulations. If your pharmacy has been identified for an Optum Rx audit, there are a number of potential defenses available to you. The first defense against an Optum Rx audit is to be proactive, and Optum Rx audit planning can lessen the chance of unfavorable findings. That said, it is often necessary to involve an attorney to hold PBMs like Optum Rx to their obligations under law and provider agreements. For this reason, national audit services and pharmacy audit consultants are often ineffective.
Optum Rx audit discrepancies and findings can be appealed based on the specific procedures outlined in the Optum Rx provider manuals. It is important to follow these requirements exactly, within the timeframes established, or your appeal rights could be lost and further review denied. In an Optum Rx appeal, it is critically important to make a complete record of why the Optum Rx audit findings or sanctions should be reversed, including through documentation, legal arguments, and corrective actions, if any. Depending on the outcome of the Optum Rx appeal, you may have further legal recourse against Optum Rx.
Optum Rx audits can have severe repercussions depending on the results of the Optum Rx audit, including recoupments, network sanctions, and criminal, civil and administrative investigations involving jail time, significant fines, and license revocation or exclusion. We publish a 10-part PBM Audit Guide that discusses the overlap between Optum Rx audits and government investigations and how to successfully manage Optum Rx audit risk. This resource is complimentary to subscribers HERE.
Once a sword, now your shield.
%402x.svg){kind=icon}
